• AevisBio

    In Science We Trust

  • AevisBio

    In Science We Trust

  • AevisBio

    In Science We Trust

About us

AevisBio is a biotech company applying
targeted protein modulator (TPM) technology
to develop new therapeutics

VIEW MORE

Pipeline

  • Pipeline
  • Indication
  • Discovery IND enabling
  • Collaboration Partners
CBMs
NIH/NIA
AEV103 TBI/AD
Severance
AEV003 PD/AD
KRIBB
SIMs
NIA, NCI
AEV302 Metastatic cancer
AEV305 Multiple myeloma
TPDs
NCI
AEV103 Drug resistant cancer
AEV003 Solid cancer
KRICT
  • AEV103
    Discovery
    CBMs
    NIH/NIA
    AEV103 TBI/AD Severance
  • AEV003
    IND enabling
    CBMs
    NIH/NIA
    AEV003 PD/AD KRIBB
  • AEV302
    Discovery
    SIMs
    NIA, NCI
    AEV302 Metastatic cancer
  • AEV305
    Discovery
    SIMs
    NIA, NCI
    AEV305 Multiple myeloma
  • AEV103
    Discovery
    TPDs
    NCI
    AEV103 Drug resistant cancer
  • AEV003
    Discovery
    TPDs
    NCI
    AEV003 Solid cancer KRICT

Video

Aevisbio drug discovery programs
Harnessing cereblon as a drug anchor
Regulate protein stability
For the treatment of diseases
From Neurological disorders
to drug resistant cancers